Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune modulation and sepsis

W Karzai1, K Reinhart

  • 1Department of Anaesthesiology and Intensive Care Therapy, University Hospital of Friedrich Schiller University, Jena, Germany.

International Journal of Clinical Practice
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sepsis incidence in Germany and worldwide : Current knowledge and limitations of research using health claims data].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2021
Same author

COVID-19 reinforces the need to improve sepsis care resources in Africa.

Infection·2021
Same author

Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis.

Intensive care medicine·2020
Same author

Correction to: Protective ventilation with high versus low positive end-expiratory pressure during one-lung ventilation for thoracic surgery (PROTHOR): study protocol for a randomized controlled trial.

Trials·2019
Same author

Protective ventilation with high versus low positive end-expiratory pressure during one-lung ventilation for thoracic surgery (PROTHOR): study protocol for a randomized controlled trial.

Trials·2019
Same author

Challenges in assessing the burden of sepsis and understanding the inequalities of sepsis outcomes between National Health Systems: secular trends in sepsis and infection incidence and mortality in Germany.

Intensive care medicine·2018
Same journal

RETRACTION: Prediction of Arrhythmia Recurrence after Atrial Fibrillation Ablation in Patients with Normal Anatomy of the Left Atrium.

International journal of clinical practice·2025
Same journal

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice.

International journal of clinical practice·2025
Same journal

Knowledge and Awareness of Osteoporosis: A Survey of Physical Therapy Providers in Saudi Arabia.

International journal of clinical practice·2024
Same journal

Efficacy and Safety of Pericapsular Nerve Group Block for Hip Fracture Surgery under Spinal Anesthesia: A Meta-Analysis.

International journal of clinical practice·2024
Same journal

The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases.

International journal of clinical practice·2024
Same journal

Blood Features Associated with Viral Infection Severity: An Experience from COVID-19-Pandemic Patients Hospitalized in the Center of Iran, Yazd.

International journal of clinical practice·2024
See all related articles

Modulating the host inflammatory response in sepsis, while effective in animal studies, has not improved survival in humans. Further research is needed to identify conditions where these sepsis therapies might succeed.

Area of Science:

  • Sepsis Pathogenesis and Treatment
  • Immunology
  • Critical Care Medicine

Background:

  • Sepsis involves microbial toxins and host inflammatory mediators.
  • Conventional sepsis treatment includes antibiotics, surgery, and supportive care.
  • Modulating host inflammatory mediators is an explored adjunctive therapy for sepsis.

Purpose of the Study:

  • To review the efficacy of modulating host inflammatory mediators in sepsis.
  • To understand the discrepancy between animal model success and human trial failures.
  • To identify future research directions for immunomodulatory sepsis therapies.

Main Methods:

  • Review of existing literature on sepsis pathogenesis and immunomodulation.
  • Analysis of clinical trial outcomes for anti-inflammatory sepsis treatments.

Related Experiment Videos

  • Comparative analysis of animal models versus human sepsis responses.

    • Main Results:

    • Inhibition of host inflammatory response has shown promise in animal sepsis models.
    • Clinical trials inhibiting host inflammatory response in human sepsis have failed to demonstrate efficacy.
    • A significant gap exists between experimental and clinical outcomes for these therapies.

    Conclusions:

    • Current immunomodulatory strategies for sepsis have not improved patient survival.
    • Further investigation is required to elucidate the specific conditions for successful immunomodulation in human sepsis.
    • Future studies should focus on identifying patient subgroups or specific inflammatory pathways that could benefit from targeted modulation.